Yuanchi Weng

Ruijin Hospital, Shanghai Jiao Tong University

Papers

15

Total Citations

466

H-Index

10

About

Dr. Yuanchi Weng is a pioneering pancreatic surgeon whose work has fundamentally reshaped the landscape of minimally invasive pancreatic surgery. His research centers on the safety, efficacy, and oncological outcomes of robot-assisted pancreaticoduodenectomy (RPD), a technically demanding procedure. Dr. Weng’s landmark studies, including his analysis of 450 RPD cases (115 citations), have been instrumental in defining the learning curve for this complex surgery, demonstrating that with experience, RPD can achieve short-term outcomes comparable to open surgery. He has further proven that, after mastering the learning curve, RPD offers equivalent oncological outcomes for pancreatic ductal adenocarcinoma, a critical finding for patient care. Beyond technique, Dr. Weng is advancing postoperative care by applying machine learning algorithms to predict pancreatic fistula, a major complication. With multiple papers exceeding 100 citations and a consistent body of work from a high-volume center, Dr. Weng is a leading voice in the robotic revolution, providing the evidence needed for surgeons worldwide to adopt these advanced techniques safely.

Research Focus

Key Achievements

10
H-Index
15
Papers
466
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
121 citations · 2020
📈 Most Prolific Year: 2020 (4 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: Ruijin Hospital, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago